Abstract
We report the case of a hypertensive 54-year-old female who had been under treatment with olmesartan (40 mg daily) for a month. She was referred due to hypertransaminasemia and also reported asthenia and a 7 kg weight loss.
MeSH terms
-
Antihypertensive Agents / adverse effects
-
Blood Pressure
-
Female
-
Hepatitis* / drug therapy
-
Humans
-
Hypertension* / drug therapy
-
Imidazoles / adverse effects
-
Middle Aged
-
Tetrazoles / adverse effects
Substances
-
Antihypertensive Agents
-
Imidazoles
-
Tetrazoles
-
olmesartan